Editorial: Liquid biopsy in oncology: opportunity and challenges

被引：0

作者：

Kumar, Ashok ^{[1
]}

Singh, Rajesh ^{[2
,3
]}

Arya, Neha ^{[4
]}

Lueong, Smiths ^{[5
]}

Jain, Aklank ^{[6
]}

机构：

[1] All India Inst Med Sci AIIMS, Dept Biochem, Bhopal, Madhya Pradesh, India

[2] Maharaja Sayajirao Univ Baroda, Dept Biochem, Vadodara, India

[3] Banaras Hindu Univ IoE, Inst Sci, Dept Mol & Human Genet, Varanasi, Uttar Pradesh, India

[4] All India Inst Med Sci AIIMS, Dept Translat Med, Bhopal, Madhya Pradesh, India

[5] Univ Klinikum Essen, Westdeutsches Tumorzentrum Essen, Essen, Germany

[6] Cent Univ Punjab, Dept Zool, Bathinda, India

来源：

关键词：

liquid biopsy; early detection of cancer; disease prognosis; personalized medicine; circulating cell free DNA;

D O I：

10.3389/fmolb.2024.1466938

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页数：3

共 3 条

[1] Prognostic and predictive role of liquid biopsy in lung cancer patients
Goksel, Tuncay
Ozgur, Su
Vardarli, Asli Tetik
Koc, Altug
Karakus, Haydar Soydaner
Ozdemir, Taha Resid
Erdogan, Kadri Murat
Aldag, Ceyda
Veral, Ali
Komurcuoglu, Berna
Gursoy, Pinar
Arayici, Mehmet Emin
Leblebici, Asim
Yigitbasi, Turkan
Ellidokuz, Hulya
Basbinar, Yasemin
[J]. FRONTIERS IN ONCOLOGY, 2024, 13
[2] NCCN, 2024, GuidelinesNRecentGuidelines
[3] U.S. Food and Drug Administration, 2021, FDA approves liquid biopsy NGS companion diagnostic test for multiple cancers and biomarkers